Americans now say they approve of free trade by 64%-27%, a margin of better than two to one. That's up from 57%-37% early in Trump's presidency, and 51%-41% near the end of...Politicsread more
Kudlow pointed to strong retail sales and low unemployment as signs that the U.S. economy remained strong.Marketsread more
The yield on the benchmark 10-year Treasury note briefly fell below the 2-year rate on Wednesday, a phenomenon in the bond market known as yield curve inversion, which is...Marketsread more
The MacBook Pro recall and its subsequent ban from flights underscores the increasing brand risk from problems with lithium-ion batteries.Technologyread more
Experts say the timing of Amazon executives' contributions to Rep. David Cicilline likely reflect the company's heightened urgency over growing regulatory scrutiny.Technologyread more
Despite aggressive strides, Waymo needs one thing before their self-driving cars become a seriously useful transportation system: people. We talked to the ones closest to it.Technologyread more
CNBC combed through Wall Street research to see which stocks are still a buy after their earnings reports.Marketsread more
Coinbase security chief Philip Martin explains, "Possession of a key is possession of your currency. What that means is that you can't revoke a cryptocurrency key, if that key...Technologyread more
Fraud investigator Harry Markopolos' accusations extended beyond GE's management to actuaries, auditors and analysts who he claims overlooked billions in liabilities.Marketsread more
The Supreme Court could strike down the constitutionality of the Consumer Financial Protection Bureau, an agency Elizabeth Warren has likened to her child and which Justice...2020 Electionsread more
Bianco Research's James Bianco suggests Wall Street is desperately looking for a signal that a 50 basis point cut is coming next month.Trading Nationread more
CVS Health Corp.: "Here's what I've been telling club members of ActionAlertsPlus.com, which follows along with my charitable trust: I think CVS is one of the absolute cheapest stocks, now that it's bought Aetna, in the country, and [CEO] Larry Merlo should come on air and tell us about it. "
Neogenomics Inc.: "Cancer genetics is a very, very big, great, speculative area. We saw that from Loxo Oncology when [Eli] Lilly bought that company. I am not going to say that you can't speculate on that. I am brazen. "
Vicor Corp.: "No. Power systems I regard as a commodity. I've looked at the company over and over again. I'm going to say don't buy."
T. Rowe Price Group: "A lot of people have turned a lot on all of these stocks that have to do with equities, picking equities. This yields 3 percent. It's a very well-run company. I'm not going to tell you to go away from it. I'm going to tell you to go toward it."
The Clorox Co.: "You are paying a high multiple for Clorox. One of my themes this week and last week was the high multiple you're paying for safety. I like Clorox. I regard it as the best of the consumer packaged goods. But always remember it is an expensive stock, and I'd prefer to get it at maybe a 3 percent yield instead of 2.6. But [CEO] Benno Dorer is doing terrific."